Uptake of high-dose therapy and peripheral blood stem cell transplantation in myeloma patients <65 years - the role of the myeloma multi-disciplinary team

Autor: Nigel H. Russell, K. Saravanamuttu, Jennifer Byrne, C. Williams, Emma Das-Gupta, V. Tringham

Publikováno v: British Journal of Haematology. 130:318-319

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86535f86d4edcb248f9bb57d8dfa2b18
https://doi.org/10.1111/j.1365-2141.2005.05601.x

Isoniazid pharmacokinetics in patients in chronic renal failure

Autor: C H, Gold, N, Buchanan, V, Tringham, M, Viljoen, B, Strickwold, G P, Moodley

Publikováno v: Clinical nephrology. 6(2)

INH pharmcokinetics was studied in 2 groups of patients in chronic renal failure. In the group on conservative treatment, INH half life was prolonged, but was not related to the degree on renal impairement. In the hemodialysis group 73% of the INH gi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5aa3838b5df642b74cf44638b8fd4ae9
https://pubmed.ncbi.nlm.nih.gov/954244

The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.

Autor: Burnett, A. K.¹ BurnettAK@Cardiff.ac.uk, Hills, R. K.¹, Hunter, A.², Milligan, D.³, Kell, J.⁴, Wheatley, K.⁵, Yin, J.⁶, McMullin, M.-F.⁷, Cahalin, P.⁸, Craig, J.⁹, Bowen, D.¹⁰, Russell, N.¹¹

Publikováno v: Leukemia (08876924). Jul2011, Vol. 25 Issue 7, p1122-1127. 6p. 4 Charts, 1 Graph.

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

Autor: Morgan GJ; The Institute of Cancer Research, Royal Marsden National Health Service Foundation Trust, London, United Kingdom. gareth.morgan@icr.ac.uk, Davies FE, Gregory WM, Szubert AJ, Bell SE, Drayson MT, Owen RG, Ashcroft AJ, Jackson GH, Child JA

Publikováno v: Blood [Blood] 2012 Jun 07; Vol. 119 (23), pp. 5374-83. Date of Electronic Publication: 2012 Apr 12.

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

Autor: Morgan GJ; Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom. gareth.morgan@icr.ac.uk, Gregory WM, Davies FE, Bell SE, Szubert AJ, Brown JM, Coy NN, Cook G, Russell NH, Rudin C, Roddie H, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA

Publikováno v: Blood [Blood] 2012 Jan 05; Vol. 119 (1), pp. 7-15. Date of Electronic Publication: 2011 Oct 20.